Downregulation of CPEB1, a sequence-specific RNA-binding protein, in a mouse mammary epithelial cell line (CID-9) causes epithelial-to-mesenchymal transition (EMT), based on several criteria. First, CPEB1 knockdown decreases protein levels of Ecadherin and b-catenin but increases those of vimentin and Twist1. Second, the motility of CPEB1-depleted cells is increased. Third, CID-9 cells normally form growth-arrested, polarized and threedimensional acini upon culture in extracellular matrix, but CPEB1-deficient CID-9 cells form nonpolarized proliferating colonies lacking a central cavity. CPEB1 downregulates Twist1 expression by binding to its mRNA, shortening its poly(A) tract and repressing its translation. CID-9 cultures contain both myoepithelial and luminal epithelial cells. CPEB1 increases during CID-9 cell differentiation, is predominantly expressed in myoepithelial cells, and its knockdown prevents expression of the myoepithelial marker p63. CPEB1 is present in proliferating subpopulations of pure luminal epithelial cells (SCp2) and myoepithelial cells (SCg6), but its depletion increases Twist1 only in SCg6 cells and fails to downregulate E-cadherin in SCp2 cells. We propose that myoepithelial cells prevent EMT by influencing the polarity and proliferation of luminal epithelial cells in a mechanism that requires translational silencing of myoepithelial Twist1 by CPEB1.
INTRODUCTION
The development, function and involution of the mammary gland requires complex interactions among a variety of cell types (Medina, 1996; Richert et al., 2000) . The epithelial compartment contains two cell types, luminal cells that line the ductal tree and form the secretory apparatus within the alveoli of lactating mammary gland, and myoepithelial cells that border the basal lamina separating epithelial cells from the extracellular matrix (Péchoux et al., 1999; Rønnov-Jessen et al., 1996) . Understanding the developmental interactions between these cell types has been aided by the establishment of cell lines that partially replicate in vitro the hormone-dependent changes in gene expression of mammary epithelial cells in vivo. One of these cell lines, CID-9 (Schmidhauser et al., 1990) , was derived from COMMA-1D cells, which were isolated from primary mammary epithelial cells of midpregnant mice (Danielson et al., 1984) . Transfer of CID-9 cultures to a laminin-rich substrate of extracellular matrix (ECM), such as Matrigel, causes them to stop proliferating and form polarized acinar structures with a central cavity (Barcellos-Hoff et al., 1989; Blatchford et al., 1995) . In the presence of the lactogenic hormones insulin and prolactin, the cells differentiate and express milk proteins, such as b-casein (Barcellos-Hoff et al., 1989) . Because CID-9 cultures contain both the luminal epithelial and myoepithelial cells, they provide a good in vitro model for cellular differentiation in the epithelial compartment of the mammary gland (Schmidhauser et al., 1990) .
Previously, we examined the mechanism of hormonedependent milk protein expression at the translational level in CID-9 cells (Choi et al., 2004; Rhoads and Grudzien-Nogalska, 2007) . After overnight removal of hormones, synthesis of milk proteins, including b-casein, was increased by insulin and further increased by insulin plus prolactin, whereas prolactin alone had no effect. Under these conditions, b-casein mRNA shifted to larger polysomes and its poly(A) tract progressively increased from ,20 to ,200 residues. Inhibition of the selective increase in milk protein mRNA translation by cordycepin confirmed that this change was due to hormoneinduced polyadenylation. One possible mechanism by which mRNA-specific polyadenylation could be regulated is through a cytoplasmic polyadenylation element (CPE) in the 39 UTR. bcasein mRNA contains a functional CPE that is sufficient for the hormone-stimulated translational enhancement and mRNA-specific polyadenylation of a reporter mRNA in CID-9 cells (Choi et al., 2004) . CPEs are recognized by CPE-binding proteins (CPEBs) (Fox et al., 1989; McGrew et al., 1989) , of which there are four paralogs in mammalian cells, CPEB1-CPEB4 (Mendez and Richter, 2001; Wang and Cooper, 2010) . CPEB1 regulates stability and translation of a subset of mRNAs through cytoplasmic polyadenylation in a variety of cell types, including germ cells (Hake and Richter, 1994; Tay and Richter, 2001) , neurons (Wu et al., 1998) and primary diploid fibroblasts (Burns and Richter, 2008; Groisman et al., 2006) . Besides the CPE, CPEB1-target mRNAs possess in their 39 UTR the polyadenylation signal, the hexanucleotide AAUAAA (Sheets et al., 1994) , which is bound by the cleavage and polyadenylation specificity factor (Dickson et al., 1999) . CPEB1 binds several other factors including a poly(A) polymerase (GLD2, also known as PAPD4) to elongate the poly(A) tract, a poly(A) ribonuclease (PARN) to deadenylate mRNA, and symplekin to stabilize the polyadenylation complex (Barnard et al., 2004; Kim and Richter, 2006) .suppressing epithelial-to-mesenchymal transition (EMT). EMT is associated with changes in cells adhesion, polarity, cytoskeleton and migration, and it is typically characterized by an upregulation of mesenchymal markers, such as vimentin, and downregulation of epithelial markers, such as E-cadherin (Godde et al., 2010; Hall, 2009; Schmalhofer et al., 2009 ). Study of EMT in vitro has revealed multiple pathways that regulate the expression of EMTrelated transcription factors such as the Snail family, ZEB1, ZEB2, Twist1 and Twist2 (Medici et al., 2008; Yang et al., 2004) . In the present work, we provide several lines of evidence that CPEB1 knockdown in CID-9 cells promotes EMT. We also demonstrate that CPEB1 increases during CID-9 cell differentiation, is expressed predominantly in myoepithelial cells and translationally downregulates Twist1.
RESULTS

CPEB1 is essential for proper CID-9 cell differentiation
We examined whether CPEB1 is important for hormonedependent expression of b-casein mRNA by reducing levels of the CPEB1 protein. CID-9 cells were separately infected with three recombinant lentiviruses expressing different short hairpin RNAs (shRNAs) directed against CPEB1 plus a non-targeting (control) shRNA. We tested whether there was an effect of the shRNAs on CPEB1 mRNA and protein levels after 4 days of selection with puromycin. CPEB1 mRNA was significantly decreased in all three cell lines expressing CPEB1-specific shRNAs (CPEB1 #1, #2 and #5) compared to uninfected and control shRNA cells (Fig. 1A, upper panel) . The greatest reduction was observed in CPEB1 #2 cells, so they were used in subsequent experiments. The levels of CPEB1 protein were also reduced, with the largest effect in CPEB1 #2 cells (Fig. 1A , middle panel).
We next investigated the effect of CPEB1 knockdown on the steady-state levels of cytosolic b-casein mRNA by reverse transcription followed by quantitative PCR (qRT-PCR) with exon-specific primers (Fig. 1B, mRNA) . CPEB1 #2 cells contained only 0.1% as much cytosolic b-casein mRNA (Fig. 1B , open bar) as cells expressing control shRNA (Fig. 1B , filled bar). Lactogenic hormones increase b-casein mRNA levels by both transcriptional and stabilization mechanisms (Guyette et al., 1979) . The diminished b-casein mRNA levels in CPEB1-knockdown cells could be due to either a lower transcription rate of the b-casein gene or higher degradation rate of cytosolic bcasein mRNA. To distinguish between the two, we measured the amounts of unspliced b-casein pre-mRNA, a measure of transcription, by the same qRT-PCR technique except that the primer pair spanned an intron-exon junction (Fig. 1B , premRNA). As observed for cytosolic b-casein mRNA, CPEB1 #2 cells contained only 0.1% as much b-casein pre-mRNA as control cells. Because CPEB1 knockdown prevented accumulation of b-casein mRNA, it was not possible to determine whether it also affected translation of b-casein mRNA.
The finding that b-casein mRNA is not made in CPEB1-deficient cells was unexpected because effects of CPEB1 on transcription have not been described. However, the appearance of b-casein mRNA is a marker for differentiation of CID-9 cells in response to their interactions with lactogenic hormones, the ECM and adjacent cells (El-Sabban et al., 2003; Schmidhauser et al., 1990) . We therefore asked whether CID-9 differentiation was affected by CPEB1 knockdown. Uninfected, control shRNA or CPEB1 shRNA cells were differentiated for 1, 2 or 5 days on Matrigel in the presence of insulin, prolactin and hydrocortisone (Fig. 1C) . Differentiation is signaled by the cessation of proliferation and the formation of three-dimensional (3D) acini. Uninfected and control shRNA cells were similar in the formation of 3D acini, but CPEB1 shRNA cells differentiated faster than the control cells, formed disorganized epithelial structures and continued to proliferate on Matrigel. These results suggest that the failure of CPEB1-knockdown cells to make b-casein mRNA is due to their failure to undergo normal differentiation.
E-cadherin is not expressed in CPEB1-knockdown CID-9 cells
We tested whether CPEB1 was required for differentiated CID-9 cell polarity by immunostaining for E-cadherin. E-cadherin is located along lateral surfaces of cells in the polarized epithelium of mammary gland as well as between adjacent cells of 3D acini formed in culture (Streuli et al., 1991) . Upon differentiation of CID-9 cells expressing control shRNA for 8 days, we found that E-cadherin was localized primarily in adherens junctions between cells that lined the hollow central cavity (Fig. 1D,  left) . By contrast, cells expressing CPEB1 shRNA exhibited significantly weaker E-cadherin staining and loss of cavity formation (Fig. 1D, right) . The changes in cell morphology and decreased E-cadherin expression suggest that CPEB1-deficent cells might have undergone EMT.
Two possible explanations for this finding are: (1) E-cadherin is expressed only after formation of 3D acini and its absence in CPEB1-knockdown cells is because CPEB1 is required for differentiation, and (2) CPEB1 is required for E-cadherin expression regardless of differentiation. To distinguish between these possibilities, we examined E-cadherin expression and cell morphology in proliferating CID-9 cells, that is, cells grown in the absence of differentiation-promoting conditions. Control CID-9 cells formed flat and regularly aligned monolayers when cultured on 2D substrata (Fig. 1E, left) . Adherens junctions were clearly visible by E-cadherin immunostaining. By contrast, depletion of CPEB1 resulted in a substantial loss of E-cadherin staining (Fig. 1E, right) . Furthermore, CPEB1-deficient cells adopted a spindle-shaped morphology but did not form regularly aligned monolayers. Thus, CPEB1 reduction downregulates Ecadherin expression regardless of the differentiation state.
CPEB1 knockdown increases the motility of CID-9 cells
During EMT, changes in epithelial cell shape are accompanied by increases in motility (Thiery, 2002) . We tested whether CPEB1 knockdown changes the motile properties of CID-9 cells with a phagokinetic track motility assay (Nogalski et al., 2012) . In this assay, a cell moving on a colloidal-gold-coated glass coverslip clears gold particles and creates a measurable tract. We found that CID-9 cells expressing CPEB1 shRNA had markedly increased motility compared to uninfected cells, but control shRNA cells were unchanged ( Fig. 2A, left) . The results of multiple experiments are quantified in Fig. 2B .
It is possible that shRNA #2 used to knockdown CPEB1 also downregulates an unrelated protein that is responsible for the increased cell motility. shRNA #2 is complementary to a sequence in the 39-UTR of mouse CPEB1. Therefore, to determine whether the effects were directly related to the loss of CPEB1, we transfected CPEB1-knockdown cells with a plasmid expressing FLAG-tagged CPEB1 encoded by an mRNA containing the CPEB1 open reading frame but an unrelated 39 UTR, in particular, one that is not complementary to shRNA #2. Expression of exogenous FLAG-CPEB1 was confirmed by western blotting (Fig. 2C) . CID-9 knockdown cells became significantly less motile upon expression of FLAG-CPEB1, but uninfected and control shRNA cells were unaffected ( Fig. 2A,B) . Therefore, the increased cell motility in CPEB1-knockdown cells is not due to non-target effects of shRNA #2.
It is also possible that the increased motility of CPEB1-knockdown cells results from an increased proliferation rate. We examined cell proliferation with the MTT assay without serum, in 0.5% serum and in 2% serum (Fig. 2D ). There was no significant difference in proliferation rate between control and knockdown cells under any conditions. Thus, the increased motility of CID-9-knockdown cells is not due to a change in proliferation rate.
CPEB1 knockdown changes the expression of EMT markers
A decrease in both E-cadherin (Kalluri and Weinberg, 2009; Thiery et al., 2009 ) and b-catenin (Chakrabarti et al., 2012 ) is observed during EMT. By contrast, several proteins increase during EMT, including the transcription factors Twist1, Snail1, Snail2 and ZEB1 (Foubert et al., 2010; Schmalhofer et al., 2009 ), which repress E-cadherin expression and are sufficient to induce EMT in various cellular contexts (Peinado et al., 2007) . In addition, elevated levels of the intermediate filament protein vimentin are a marker for EMT (Satelli and Li, 2011) .
We wished to examine how CPEB1 influenced the levels of these EMT markers at various stages of CID-9 differentiation. First, it was necessary to know whether CPEB1 levels themselves changed during differentiation. We analyzed CPEB1 mRNA by qRT-PCR in proliferating cells (day 0) and those differentiating for 2 and 4 days. Interestingly, we found that the CPEB1 mRNA level was significantly elevated (,7-fold) in differentiating versus proliferating cells (Fig. 3A, open bars) . The expression of CPEB1 protein also increased during differentiation, as did that of E-cadherin and b-catenin, whereas that of vimentin decreased (Fig. 3B , left three lanes). Knockdown of CPEB1 had the opposite effect, decreasing the expression of CPEB1, Fig. 1 . CPEB1 depletion changes the morphology, E-cadherin expression and proliferation on Matrigel of CID-9 cells. (A) Proliferating CID-9 cells were either uninfected, infected with lentiviruses expressing non-targeting shRNA (control), or expressing three different shRNAs against CPEB1 (#1, #2 and #5). CPEB1 mRNA levels were measured by qRT-PCR (upper panel), and CPEB1 protein levels were measured by western blotting (WB, middle panel). GAPDH was a loading control. Molecular masses of proteins (in kDa) were estimated from the mobilites of protein markers: CPEB1, 64; GAPDH, 38. Protein markers ranged from 17 to 225 kDa, but only the positions of those that fall within the portion of the western blot shown are indicated. (B) b-casein pre-mRNA (containing introns and exons) or mature mRNA (containing only exons) were measured by qRT-PCR in differentiating CID-9 cells expressing either control (filled bars) or CPEB1 shRNA #2 (open bars). Primers for premRNA spanned an intron-exon junction, whereas primers for mature mRNA corresponded to exons only. The level of b-casein RNA in control cells was set as 1. The experiment was performed three times. (C) Phase-contrast images of uninfected, control and CPEB1-depleted CID-9 cells in 3D-ontop cultures differentiated for 1, 2 or 5 days (d1, d2 and d5, respectively). (D) Control and CPEB1-deficent CID-9 cells were grown for 8 days under 3D-on-top conditions. Colonies were immunostained on Matrigel and analyzed for Ecadherin by confocal microscopy (green). DNA was counterstained with DAPI (blue). Sections through the centers of the colonies are shown. Scale bars: 50 mm. (E) Proliferating control and CPEB1-deficent CID-9 cells were grown to confluence on plastic and immunostained for Ecadherin (green), F-actin (red) and DNA (blue). Scale bars: 25 mm.
E-cadherin and b-catenin, while increasing the expression of Twist1 and vimentin (Fig. 3B , right three lanes). The mRNAs for Twist1, ZEB1 and the mesenchymal marker N-cadherin were significantly elevated by CPEB1 knockdown in CID-9 cells differentiated for 6 days but not those of Snail1, Snail2 or CPEB4, another CPEB family member (Fig. 3C ). The same changes in protein expression caused by CPEB1 knockdown occur in proliferating cells (Fig. 3D ), indicating that they do not reflect a failure to differentiate.
To test whether the observed elimination of E-cadherin expression was due to CPEB1 silencing per se and not to offtarget effects of shRNA #2, we expressed FLAG-CPEB1 in proliferating CID-9 cells depleted of endogenous CPEB1 and immunostained for E-cadherin. CPEB1-deficient cells had less Ecadherin (Fig. 4A , compare the middle with the top panels) while FLAG-CPEB1-overexpressing cells had normal Ecadherin levels and retained their epithelial characteristic of forming tight clusters ( Fig. 4A ; compare the bottom with the top panels).
CPEB1 knockdown does not alter E-cadherin expression in EpH4 cells
While this study was in progress, results were published showing that knockdown of CPEB1 diminished tight-junction formation in a different mouse mammary epithelial cell line termed EpH4 (Nagaoka et al., 2012) . EpH4 cells are a derivative of IM-2 cells, which were originally isolated from mammary tissue of a midpregnant mouse (Reichmann et al., 1989) . Nagaoka et al. reported that CPEB1 knockdown interfered with the apical localization of ZO-1 mRNA and impaired central cavity formation, which indicates a loss of cell polarity. There are several differences between the observations of Nagaoka et al. with CPEB1-deficient EpH4 cells and ours with CPEB1-deficient CID-9 cells. Those authors observed no change in expression of E-cadherin or bcasein whereas we found a dramatic decrease (Figs 1, 3 and 4). They observed no change in cell motility, whereas we found a marked increase (Fig. 2) . They reported no proliferation or EMTlike appearance when EpH4 cells were placed on Matrigel, but we found substantial proliferation and an EMT-like appearance for CID-9 cells (Fig. 1C) .
Because of these differences, we obtained EpH4 cells and depleted CPEB1 with the same lentiviruses that express control and CPEB1-targeted shRNAs that we used for CID-9 cells. In both cell lines, a central cavity was observed in control shRNA cells after 6 days of differentiation (Fig. 4B , left panels) but not in CPEB1 shRNA cells (Fig. 4B , right panels). However, whereas tight clusters lacking a central cavity were formed upon CPEB1 knockdown in EpH4 cells (Fig. 4B, upper right panel) , CID-9 cells were disorganized and continued to proliferate after CPEB1 knockdown (Fig. 4B , lower right panel). EpH4 cells expressed Ecadherin before and after CPEB1 knockdown (Fig. 4B , upper panels), but CID-9 cells expressed E-cadherin only before CPEB1 knockdown (Fig. 4B, lower left panel) . Given that we obtained the same results as Nagaoka et al. when CPEB1 was depleted in EpH4 cells, the differences between EpH4 and CID-9 cells in our hands are not due to differences in the shRNA used but rather to the cell lines themselves.
CPEB1 knockdown alters expression of markers specific for myoepithelial cells A clue to these differences might lie in the fact that the CID-9 cell line contains both luminal epithelial and myoepithelial cells (Desprez et al., 1993; Schmidhauser et al., 1990) whereas EpH4 is a pure luminal epithelial cell line. We therefore hypothesized that the EMT-like behavior of CID-9 cells upon CPEB1 knockdown might be due to the presence of myoepithelial cells. Myoepithelial cells are localized between luminal epithelial cells and the basement membrane (Gudjonsson et al., 2005) . They are responsible for the contractile properties of alveoli-like structures, owing to the expression of a-smooth muscle actin, and they also function to maintain polarity of luminal epithelial cells. We tested whether both myoepithelial and luminal epithelial cells were present in our CID-9 cultures. Sub-confluent cells were cultured on plastic for 24 h and immunostained for two myoepithelial cell-specific markers, the tumor suppressor protein p63 and cytokeratin 17 (CK17, also known as KRT17), and for one luminal epithelial cell marker, cytokeratin 19 (CK19, also known as KRT19) (Fig. 5A) . A subset of cells was positive for p63 and CK17 but negative for CK19, whereas another subset was positive for CK19 but negative for p63 and CK17. This indicates that our CID-9 cultures consist of at least two cell types.
Because CPEB1 knockdown severely diminishes E-cadherin in both proliferating and differentiating CID-9 cultures (Figs 1, 3 and 4), and because there is higher expression of E-cadherin in luminal epithelial than in myoepithelial cells (Chanson et al., 2011) , we wished to determine whether CEPB1 knockdown would affect expression of a myoepithelial-specific protein. In CID-9 cells differentiated for 6 days, p63 was expressed only in the outer myoepithelial layer of control shRNA cells (Fig. 5B , upper panels) but was not detectable in CPEB1 shRNA cells (Fig. 5B , lower panels). Total p63 was assayed by western blotting in extracts of CID-9 cells at various stage of differentiation. As observed previously for CPEB1, E-cadherin and b-catenin (Fig. 3B ), the expression of p63 increased during differentiation (Fig. 5C , left three lanes) but was undetectable in CPEB1-knockdown cells at all stages of differentiation (Fig. 5C , right three lanes). These results indicate that CPEB1 is required for expression of at least one myoepithelial-specific protein.
CPEB1 knockdown differentially affects CID-9 subpopulations
The observations that CPEB1 knockdown has different effects on CID-9 and EpH4 cells (Fig. 4) and that CID-9 cells contain both myoepithelial and luminal epithelial cells (Fig. 5) raised the question of which cell type predominantly expresses CPEB1 and which is responsible for the consequences of CPEB1 knockdown on CID-9 cultures. CPEB1 was visualized by immunofluorescence in CID-9 cells that were differentiated for either 2 or 6 days. CPEB1 was predominantly localized in the cytosol of the outer layer of cells, even as early as day 2 (Fig. 6A , upper panels). By day 6, when 3D acini were well formed, it was clear from their peripheral location that these were the myoepithelial cells (Fig. 6A, lower panels) . Further evidence that these were indeed myoepithelial cells comes from their expression of the myoepithelial markers b4 integrin and P-cadherin (also known as cadherin-3) (Fig. 6B) (Allen et al., 2014; Jones et al., 1997; Palacios et al., 1995) .
CPEB1 is present predominantly in differentiated myoepithelial cells (Fig. 6A) , but E-cadherin is expressed at higher levels in luminal epithelial cells than myoepithelial cells (Chanson et al., 2011) , which is in agreement with our detection of E-cadherin at adherens junctions of luminal epithelial cells ( Fig. 1D; Fig. 4B ). The observation that CPEB1 knockdown downregulates E-cadherin ( Fig. 1D; Fig. 3B; Fig. 4B ) could be explained by either an intercellular model -CPEB1 activity in myoepithelial cells affects E-cadherin expression in luminal epithelial cells; or an intracellular model -CPEB1 acts entirely within luminal epithelial cells to affect E-cadherin expression. To distinguish between these models, we studied CPEB1 knockdown in two clonal cell lines originally obtained as subpopulations from CID-9 cells, a luminal epithelial line termed SCp2 and a myoepithelial line termed SCg6 (Desprez et al., 1993) . Importantly, co-culture of SCp2 and SCg6 cells in the presence of lactogenic hormones produces the same 3D acini and b-casein expression that are characteristic of CID-9 cells (Desprez et al., 1993) . Each line was infected with lentiviruses expressing either control or CPEB1 shRNA, cultured under proliferation conditions and tested for protein expression by western blotting. Control and CPEB1 shRNA lines of CID-9 and EpH4 cells were tested in the same experiment. CPEB1 expression was similar in all four cell lines (Fig. 7A, left lanes) and was downregulated by CPEB1 shRNA (Fig. 7A, right lanes) . Twist1 was also present in all four lines, but it was higher in the lines containing myoepithelial cells (CID-9 and SCg6). It was only in these lines that CPEB1 depletion increased Twist1 expression (Fig. 7A , right lanes). E-cadherin expression was restricted to the lines containing luminal epithelial cells (CID-9, EpH4 and SCp2). However, its levels were significantly lower in CID-9 than in its clonal derivative SCp2. Importantly, E-cadherin was not affected by CPEB1 knockdown in the homogeneous luminal epithelial lines, EpH4 and SCp2, but was abolished in the heterogeneous CID-9 population. The motility of the myoepithelial line SCg6 was increased by CPEB1 shRNA whereas that of the luminal Fig. 4 . E-cadherin expression in CID-9 and EpH4 cells. (A) Proliferating CPEB1-deficient CID-9 cells were transfected with a plasmid expressing FLAG-CPEB1 and analyzed 24 h later for immunofluorescence of E-cadherin (green). DNA was counterstained with DAPI (blue). Scale bars: 50 mm. (B) CID-9 and EpH4 cells expressing control or CPEB1 shRNA were grown for 6 days under 3D-on-top conditions and immunostained as in A. Scale bars: 25 mm. CID-9 and EpH4 cells were processed in two separate experiments.
epithelial line SCp2 was unchanged (Fig. 7B) , indicating that the increase in CID-9 cell motility ( Fig. 2A) is due to the myoepithelial subpopulation. These results support the intracellular model proposed above, that CPEB1 expression in myoepithelial cells influences the behavior of luminal epithelial cells, perhaps by translational regulation of myoepithelial proteins that convey differentiation signals to luminal epithelial cells.
CPEB1 directly regulates translation of Twist1 mRNA
To gain insight into the molecular mechanism by which CPEB1 triggers EMT in CID-9 cells, we asked whether CPEB1 interacts with mRNAs encoding EMT-related proteins. The fact that mRNAs encoding E-cadherin, Twist1 and ZEB1 contain potential CPEs in their 39 UTRs (Fig. 8A) suggests that CPEB1 could directly regulate their translation (Nagaoka et al., 2012; Nairismägi et al., 2012) . Twist1 is particularly interesting, given the effects of CPEB1 knockdown on CID-9 cell motility (Fig. 2) , because Twist1 is required for cell migration during both development (Chen and Behringer, 1995) and oncogenesis (Ma et al., 2007) . Using RNA immunoprecipitation (Bava et al., 2013) in proliferating CID-9 cells, we found that CPEB1 is bound to Twist1 and ZEB1 mRNAs but not E-cadherin or N-cadherin mRNAs (Fig. 8B) . Interestingly, CPEB1 also bound the mRNA for p63, although a CPE within p63 mRNA has not previously been identified.
Because CPEB1 was originally identified as a polyadenylation factor (Hake and Richter, 1994) and because polyadenylation strongly stimulates translation (Wakiyama et al., 2000; Wells et al., 1998) , we asked whether the polyadenylation status of EMT-related mRNAs was altered by CPEB1 depletion in CID-9 cells. Fig. 8C shows the results of an RNA-ligation-coupled RT-PCR assay for Twist1 mRNA. Primer set #1 amplifies a region from just upstream of the poly(A) addition site to the 39-terminus of the poly(A); hence, the size of the amplified product reflects the size of the poly(A) tract. The size of Twist1 mRNA lacking any poly(A) was determined by digesting with RNase H in the presence of oligo(dT), which completely removes poly(A) (Fig. 8C, lanes 3, 4, 7 and 8) . Comparison of the 229-bp band from the RNase H control (Fig. 8C, lane 3) to the control CID-9 cells (Fig. 8C, lane 1) indicates that the poly(A) tail of Twist1 mRNA is very short and homogeneous. [The band at ,100 bp is also seen in the no-template control (lane 9) and is therefore non-specific.] It became heterogenous, with a median length of ,200 nt upon CPEB1 knockdown (lane 2), the heterogeneity being typical of actively translated mRNAs (Charlesworth et al., 2004) . Primer set #2 amplifies a sequence in the 39 UTR of Twist1 mRNA that is upstream of the poly(A) addition site (lanes 5-8) and indicates that CPEB1 knockdown did not change the total amount of Twist1 mRNA. Thus, the binding of CPEB1 to the CPE of Twist1 mRNA results in a very short poly(A) tract. By contrast, CPEB1 caused no change in the poly(A) length of E-cadherin or p63 mRNAs (Fig. 8D ), or ZEB1 (data not shown).
Poly(A) lengthening upon CPEB1 knockdown would be expected to result in more efficient translation of Twist1 mRNA. We tested this by determining the polysomal distribution of Twist1 mRNA in extracts of proliferating control and CPEB1-depleted CID-9 cells (Fig. 8E) . In control cells, a substantial portion of Twist1 mRNA was in the untranslated region of the gradient (Fig. 8E , middle panel, black line, fractions 1-2), but in CPEB1-knockdown cells, all of this shifted to polysomes (Fig. 8E , red line, fractions 5-12), which represents an increase in translational efficiency. Translation of GAPDH mRNA, which does not contain a CPE, was unchanged by CPEB1 knockdown (Fig. 8E, lower  panel) . Overall, these data indicate that CPEB1 acts in CID-9 cells as negative regulator of Twist1 expression at the translational level, binding to Twist1 mRNA, shortening its poly(A) tract and inhibiting its translation.
DISCUSSION
CPEB1 is known to control a wide spectrum of biological processes (Fernández-Miranda and Méndez, 2012) . A potential tumor suppressive role for CPEB1 has been suggested by the observation that its levels are decreased in several types of human cancers, including ovarian cancer (Hansen et al., 2009) , multiple myeloma (Heller et al., 2008) and gastric cancer, and cell lines derived from breast and colorectal cancer (Caldeira et al., 2012) . The absence of CPEB1 increases resistance to nutritional stress, leading to the survival of rapidly dividing tumor cells as the levels of available nutrients drop (Zhang et al., 2010) . CPEB1-deficient human foreskin fibroblasts proliferate more rapidly and exhibit a shift from mitochondrial respiration to glycolysis (Burns and Richter, 2008) . Downregulation of CPEB1 is also associated with invasion by malignant cells and angiogenesis (Caldeira et al., 2012) .
In this report, we provide evidence suggesting that CPEB1 maintains the normal characteristics of differentiated mammary epithelial cells and prevents malignant transformation by inhibiting EMT, thus providing a possible mechanistic link between diminished CPEB1 levels and the human tumors noted above. Our conclusion that CPEB1 loss induces EMT in CID-9 cells is supported by their increased cell motility, proliferation on Matrigel, upregulation of the key EMT transcription factors Twist1 and ZEB1, and downregulation of E-cadherin and b-catenin. The mRNAs encoding three of these factors possess functional CPEs in their 39 UTRs. We further show that CPEB1 represses expression of Twist1 in CID-9 cells by binding to its mRNA, shortening its poly(A) tract and downregulating its translation. Our finding that CPEB1-depleted CID-9 cells undergo EMT contrasts with EpH4 cells in which no such phenotype was observed after CPEB1 silencing (Nagaoka et al., 2012) . It has been previously shown that EpH4 cells require Ras transformation to be primed for EMT induction (Oft et al., 1996) , whereas SCp2 cells are responsive to EMT-inducing stimuli without prior transformation (Lochter et al., 1997) . It has also been demonstrated that embryonic fibroblasts from CPEB1-knockout mice do not form tumors when injected into athymic mice unless the cells are transformed with oncogenic Ras (Groisman et al., 2006) . The above findings suggest that CID-9 cells have additional genomic alterations that induce an EMT-like phenotype when CPEB1 is depleted. In fact, the parental COMMA-1D cells possess mutations in p53 (Jerry et al., 1994; Merlo et al., 1994) . Regardless of whether genomic differences explain why EpH4 and SCp2 cells, both luminal epithelial cell lines, differ with respect to EMT induction, we provide evidence in the current report that changes in myoepithelial cells are responsible for the EMT phenotype after CPEB1 knockdown. Luminal epithelial and myoepithelial cells have specific roles and locations within both mammary gland alveoli (Muschler and Streuli, 2010 ) and the alveoli-like structures that form upon Where indicated, the RNA was first incubated with oligo(dT) and RNase H to remove poly(A). Primer set #1 amplifies a region from just upstream of the poly(A) addition site to the 39-terminus of the poly(A) tract, and primer set #2 amplifies a sequence in the 39 UTR of Twist1 mRNA upstream of the poly(A) addition site. NTC, no-template control for primer sets #1 and #2. (D) Same as C, but for p63 and E-cadherin mRNAs. The primer sets were similar to primer set #1 for Twist1 mRNA. (E) Extracts from the same cells were subjected to ultracentrifugation on 10-45% sucrose gradients and fractions of 1 ml were collected. Sedimentation was monitored by absorbance at 260 nm (upper panel). The relative amounts of Twist1 (middle panel) and GAPDH (lower panel) mRNAs were quantified by qRT-PCR.
CID-9 differentiation. Because CPEB1 is expressed primarily in differentiated myoepithelial cells, and because myoepithelial cells function to maintain polarity of luminal epithelial cells (Gudjonsson et al., 2002; Runswick et al., 2001) , the loss of 3D acini organization and onset of EMT upon CPEB1 knockdown suggests that an essential organizing function of myoepithelial cells is mediated through CPEB1.
We also examined the effect of CPEB1 depletion in the homogeneous luminal epithelial cell lines SCp2 and EpH4, and the homogeneous myoepithelial cell line SCg6. We found that CPEB1 downregulation significantly increases Twist1 expression, but exclusively in myoepithelial cells. However, even though both CPEB1 and E-cadherin are present in the homogeneous luminal cell populations, knockdown of CPEB1 fails to affect E-cadherin. By contrast, both E-cadherin mRNA and protein are markedly reduced in CPEB1-deficient CID-9 cells. We attribute this difference to the fact that CID-9 cultures contain both myoepithelial and luminal epithelial cells whereas SCp2 and EpH4 cultures are homogeneous populations consisting only of the latter. Thus, even though E-cadherin mRNA contains CPEs, its expression is not controlled directly by CPEB1 in the luminal epithelial cell population of CID-9 cultures but rather by the activity of CPEB1 in myoepithelial cells. This idea is supported by the observation that loss of myoepithelial cells represses the normal production and distribution of E-cadherin, subsequently leading to EMT and increased cell motility (Kang and Massagué, 2004; Strizzi et al., 2004) .
Because localization of myoepithelial cells on the outer basal layer of 3D acini is lost upon CPEB1 depletion, it suggests that CPEB1 is important for proper myoepithelial cells differentiation. This idea is also supported by the finding that depletion of CPEB1 almost completely abolishes expression of the myoepithelial marker p63 in differentiated CID-9 cells. One of the key features of myoepithelial cells is the production of basement membrane proteins such as laminin-111 and secretion of inhibitors of ECM-degrading proteases, such as maspin (Allinen et al., 2004; Gudjonsson et al., 2002; Streuli, 2002) . Disruption of both of these processes is evident in cancer-associated myoepithelial cells. Proper functioning of myoepithelial cells is also crucial for establishing apical-basal polarity, and the loss of polarity causes the tumor phenotype Weaver et al., 1997; Zhan et al., 2008) . Myoepithelial cells are considered to be natural tumor suppressors (Pandey et al., 2010) . During breast cancer progression they are outnumbered by cancer cells and gradually disappear. Our results suggest that CPEB1 silencing causes improper differentiation of myoepithelial cells, leading to disorganization of luminal epithelial cells. Instead of differentiating and forming polarized structures, the luminal cells start to proliferate. This is seen in the lack of cavity formation and extensive cell proliferation on Matrigel after several days of differentiation. Therefore, we propose that downregulation of CPEB1 in myoepithelial cells prevents them from exerting an organizing effect on luminal cells. The presence of CPEB1 in myoepithelial cells could have an additional developmental role because these cells are known to contain multipotent stem cells capable of generating both basal and luminal cell lineages Stingl et al., 2006; van Amerongen et al., 2012) . For the parental COMMA-1D line, only the basal (myoepithelial-like) cell population possesses the capacity to regenerate the gland in transplants (Deugnier et al., 2006) .
MATERIALS AND METHODS
Hormones, cells, plasmids,and antibodies
Ovine prolactin was donated by Albert F. Parlow (National Hormone and Peptide Program, NIH, Bethesda, MD, USA). Insulin from bovine pancreas and hydrocortisone were purchased from Sigma-Aldrich (St. Louis, MO, USA). The mouse mammary epithelial cell line CID-9 (Schmidhauser et al., 1990) and two clonal derivatives, SCp2 and SCg6 (Desprez at al., 1993) were donated by Mina Bissell (Lawrence Berkeley National Laboratory, Berkeley, CA, USA). EpH4 cells (Reichmann et al., 1989) were donated by Ernst Reichmann (University Children's Hospital Zurich, Zurich, Switzerland). The plasmid FLAG-mCPEB1 containing the FLAG sequence fused at the N-terminus to the mouse CPEB1 coding sequence was provided by Raul Mendez (Institute for Research 
Culture and differentiation of cells
Proliferating CID-9, SCp2, SCg6, and EpH4 cells were grown on 100-mm dishes in DMEM/F12 (Lonza, Allendale, NJ, USA), 2% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA), 5 mg/ml insulin and 50 mg/ml gentamicin sulfate (Lonza, Allendale, NJ, USA). Cells (5610 4 ) were seeded on 24-well plates pre-coated with 120 ml of growthfactor-reduced Matrigel (BD Biosciences, Bedford, MA, USA) and were induced to differentiate in DMEM/F12 by removal of serum and addition of 5 mg/ml insulin, 1 mg/ml hydrocortisone, 3 mg/ml prolactin, 50 mg/ml gentamicin sulfate and Matrigel to 10% of the final volume, which constitutes the 3D-on-top conditions previously described (Lee et al., 2007) . Differentiation was followed for up to 12 days.
Lentiviral shRNA transduction
293T cells were co-transfected with lentiviral constructs and packaging plasmids by the calcium phosphate method (Kingston et al., 2003) . Virus-containing supernatants were collected 48 h after transfection and titered. Target cells were infected at a multiplicity of infection (MOI)52 in the presence of 6 mg/ml polybrene (Sigma-Aldrich). Infected cells were selected with 2.5 mg/ml puromycin (Sigma-Aldrich) 24 h after infection and kept in puromycin for at least 4 days prior to analysis.
Plasmid transfection
Proliferating CID-9 cells (1.6610 5 cells per well in a 24-well plate) were transfected with FLAG-tagged mouse CPEB1 using Lipofectamine 2000 (Life Technologies, Grand Island, NY, USA). Cells were prepared for the phagokinetic track motility assay after 6 h. Alternatively, cells were immunostained for E-cadherin after 24 h.
Phagokinetic track motility assay CID-9 cells (10 3 ) were transferred to colloidal-gold-coated coverslips (Nogalski et al., 2012) in 12-well plates and kept for 18 h at 37˚C under 5% CO 2 . Individual images were captured, and the average area of colloidal gold cleared by at least ten cells was determined for each well with ImageJ software (Abramoff et al., 2004) .
Proliferation assay CID-9 cells were plated in 96-well plates at 2610 3 cells per well in DMEM/F12 containing 5 mg/ml insulin and various FBS concentrations. The cell number was determined after different time intervals using MTT (Molecular Probes, Eugene, OR, USA) and a standard microplate absorbance reader.
Immunostaining of 3D-on-top cultures Differentiated CID-9 or EpH4 cells were fixed and immunostained directly in Matrigel as previously described (Lee et al., 2007) . Briefly, at the indicated times during differentiation, cells were washed with PBS and fixed with 4% paraformaldehyde for 10 min at room temperature and washed three times with PBS for 10 min each time. For blocking, slides were spread with a solution containing 0.3% Triton X-100, 5% donkey serum, and 1% goat F(ab9)2 anti-mouse immunoglobulin G (H + L) (Life Technologies) in PBS. Slides were incubated for 1.5 h at room temperature followed by an overnight incubation at 4˚C with primary antibodies in PBS containing 0.3% Triton X-100 and 1% IgG-free and protease-free BSA (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). Slides were washed three times for 20 min each time in PBS, incubated with Alexa-Fluor-tagged secondary antibodies for 45 min at room temperature, and washed twice for 20 min each time with PBS. DNA was then counterstained with DAPI (0.5 mg/ml in PBS) for 5 min at room temperature. Cells were washed for 10 min with PBS and mounted in Gold Antifade (Life Technologies). All immunofluorescence images were captured by confocal microscopy with a 636 objective (Leica TCS SP5 Spectral Confocal Microscope) and processed with Adobe Photoshop software.
Immunostaining of 2D cultures
Proliferating CID-9 cells (1. 2610 5 ) were seeded in 12-well plates in DMEM/F12 containing 2% FBS, 5 mg/ml insulin and 50 mg/ml gemtamicin and were maintained for 24 h. Cells were fixed, immunostained and imaged as described above for 3D cultures with exception that 1% goat F(ab9)2 anti-mouse immunoglobulin G (H + L) was omitted in the blocking solution.
Quantitative reverse transcriptase PCR Total cellular RNA was harvested with TRIzol LS ReagentH (Life Technologies) and treated with DNase (Promega, Madison, WI, USA) according to the manufacturers' protocols. Reverse transcription was performed on 400 ng of RNA in 20-ml reaction mixtures containing 5.5 mM MgCl 2 , 500 mM of each dNTP, 2.5 mM random hexamers, 0.2 units of RNase inhibitor and 0.8 units of MultiScribe reverse transcriptase (Life Technologies). Reaction mixtures were incubated for 10 min at 25˚C, for 30 min at 48˚C and for 5 min at 95˚C. qRT-PCR was performed with the following primers designed with the Beacon Designer tool (Bio-Rad Laboratories, Hercules, CA, USA): b-casein pre-mRNA, 59-TCTGAGGTAAGAGTTTATATTGA-39 and 59-GAAATACTATC-AGTCTGTAAACA-39; b-casein mRNA, 59-TGTATCCTCTGAGACT-GA-39 and 59-CCATGAGATTCACCTTCT-39; CPEB1, 59-TTTCAAG-CCTTCGCATTTCCC-39 and 59-GGACCCAACGCCCATCTTTA-39; CPEB4, 59-CCTTCTTCCTCCACTATA-39 and 59-GAGAGCACCAT-TATTAGC-39; E-cadherin, 59-TTTTCGGAAGACTCCCGATTCA-39 and 59-AGCTTGTGGAGCTTTAGATGC-39 (for total mRNA) or 59-TATGTGTGTGGGTGCTGATAAT-39 and 59-TGCATCTTAGAGAA-CGGTTTCA-39 (for RNA IP); N-cadherin, 59-CTGATAGCCCGGTTT-CACTTG-39 and 59-CAGGCTTTGATCCCTCTGGA-39; Snail1, 59-CACACGCTGCCTTGTGTCT-39 and 59-GGTCAGCAAAAGCACGG-TT-39; Snail2, 59-TGGTCAAGAAACATTTCAACGCC-39 and 59-GGTGAGGATCTCTGGTTTTGGTA-39; Twist1, 59-GGACAAGCTG-AGCAAGATTCA-39 and 59-CGGAGAAGGCGTAGCTGAG-39 (for total RNA) or 59-AAACCATACTTCCTCTGAAGG-39 and 59-GC-ATTTAGACACCGGATCTATT-39 (for RNA IP); ZEB1, 59-GCTGG-CAAGACAACGTGAAAG-39 and 59-CGGAGAAGGCGTAGCTGAG-39; p63 59-AGATCCCTGAACAGTTCCGAC-39 and 59-CGACGAG-AATCCATGTCAAAGTT-39; and 18S rRNA, 59-CGAGCCGCCTGGA-TACC-39 and 59-CAGTTCCGAAAACCAACAAAATAG-39. Amplification and detection were performed with the iCycler IQ real-time PCR detection system in 10-ml reaction mixtures containing 4.5 ml of the transcription reaction mixture (50 ng of cDNA), 5 ml of SsoAdvanced SYBR Green Supermix and 0.3 mM primers (Bio-Rad). The incubation conditions consisted of 3 min at 95˚C followed by 40 cycles, each of 15 s at 95˚C, and 1 min at 60˚C. Relative mRNA levels were normalized to 18S rRNA and calculated as described in User Bulletin No. 2 for the ABI Prism 7700 Sequence Detection System.
Western blot analysis
Cells were lysed in 16 NuPAGEH LDS Sample Buffer (Life Technologies) containing protease inhibitors (Roche Applied Science, Indianapolis, IN, USA) and phosphatase inhibitor cocktail 2 and 3 (Sigma-Aldrich). Equal protein amounts of the different samples were separated by SDS-PAGE on NuPAGEH NovexH 4-12% Bis-Tris Gel (Life Technologies) and transferred to ImmunoBlot polyvinylidene difluoride membranes (Bio-Rad). The blots were incubated with primary antibodies in Tris-buffered saline with 0.01% Triton X-100 (TBST) buffer supplemented with 5% BSA (Sigma-Aldrich), then with secondary antibodies conjugated to horseradish peroxidase. Proteins were detected using the ECL western blotting substrate (ThermoScientific).
RNA immunoprecipitation
Four 100-mm dishes of 80% confluent CID-9 cells were washed with PBS, cross-linked with 1% formaldehyde for 10 min at room temperature and treated with 0.125 M glycine. After washing twice with PBS, cells were lysed in lysis buffer [20 mM HEPES pH, 7.5, 1.5 mM MgCl 2 , 150 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 10% glycerol, 1% NP-40, RNase inhibitors (20 U/ml; Life Technologies) and 16 protease inhibitors (Roche Applied Science)]. Lysates were precleared with protein-A-agarose and subjected to immunoprecipitation with anti-CPEB1 antibodies or with rabbit IgG overnight at 4˚C. Immunoprecipitates were washed with the following buffers supplemented with RNase inhibitors: lysis buffer, FA500 [50 mM HEPES pH 7.5, 1 mM EDTA, 500 mM NaCl, 0.1% (w/v) sodium deoxycholate and 1% Triton X-100], LiCl wash [10 mM Tris-HCl pH 8.0, 1 mM EDTA, 250 mM LiCl, 0.1% (w/v) sodium deoxycholate and 0.5% NP-40] and TE buffer. Beads were resuspended in elution buffer (100 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS). After elution, 80 mg of proteinase K and NaCl to a final concentration 200 mM were added to the supernatant. The samples were incubated for 1 h at 42˚C and 1 h at 65˚C, and then RNA was extracted for qRT-PCR analysis as specified above.
RNA-ligation-coupled RT-PCR
Total RNA (5 mg) was subjected to RNA-ligation-coupled RT-PCR as previously described (Charlesworth et al., 2004) . The final PCR reaction was performed for 30 cycles in 25-ml reaction mixtures with a 60˚C annealing temperature. Twist1 primers set #1 consisted of an upstream primer complementary to a region in the 39 UTR of Twist1 mRNA near the poly(A) addition site (59-AAACCATACTTCCTCTGAAGG-39) and a downstream primer complementary to the anchor oligonucleotide but also containing a TTTTT tract (59-GCTTCAGATCAAGGTGACCTTTTT-39). In some cases the initial RNA samples were treated with RNase H and oligo(dT) to remove poly(A) prior to RNA ligation. Twist1 primers set #2 (59-AAACCATACTTCCTCTGAAGG-39 and 59-GCATTTAGACACC-GGATCTATT-39) amplified a sequence in the 39 UTR of Twist1 mRNA. The PCR products were resolved on 1.5% agarose gels. medium, and lysed in 500 ml of 50 mM Tris-HCl pH 7.5, 100 mM KCl, 10 mM MgCl 2 , 0.5% NP-40, 2 mM DTT, 1 mg/ml heparin, 0.1 mg/ml cycloheximide and 16 protease inhibitors (Roche Applied Science). After centrifugation at 14,000 g for 10 min, the supernatant was layered on a 15-45% sucrose gradient and centrifuged in a Beckman SW41Ti rotor at 38,000 rpm (284,000 g) at 4˚C for 2 h. Gradients were fractionated with continuous monitoring of absorbance at 260 nm. RNA from each fraction (1 ml) was isolated using TRIzol LS ReagentH (Life Technologies) and analyzed by qRT-PCR.
